Similarly, in bladder cancer, miR-1 mediates tumor suppression by directly targeting Golgi phosphoprotein 3 (GOLPH3), inhibiting FOXO1 and AKT phosphorylation [23]. This evidence concerns the gene AKT1 and urinary bladder carcinoma.